Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather Myler

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Bioanalysis|February 27, 2016
Validation of an integrated series of ligand-binding assays for the quantitative determination of antibody-drug conjugates in biological matricesHeather Myler, Vangipuram S Rangan, Alex Kozhich, et al.
The AAPS Journal|January 18, 2011
Bioanalytical approaches to quantify "total" and "free" therapeutic antibodies and their targets: technical challenges and PK/PD applications over the course of drug developmentJean W Lee, Marian Kelley, Lindsay E King, et al.
The AAPS Journal|March 15, 2022
Biological Matrix Supply Chain Shortages: More Matrices Are Now Rare-the Case for Surrogate MatricesEvan A Dubiel, Heather Myler, Mark E Arnold, et al.
Bioanalysis|June 21, 2018
Concerted application of LC-MS and ligand binding assays to better understand exposure of a large molecule drugWeifeng Xu, Hao Jiang, Craig Titsch, et al.
Bioanalysis|June 10, 2016
Antibody-drug conjugate bioanalysis using LB-LC-MS/MS hybrid assays: strategies, methodology and correlation to ligand-binding assaysJian Wang, Huidong Gu, Ang Liu, et al.
Diabetes|January 3, 2012
FGF21 analogs of sustained action enabled by orthogonal biosynthesis demonstrate enhanced antidiabetic pharmacology in rodentsJames Mu, Jason Pinkstaff, Zhihua Li, et al.
Bioanalysis|July 31, 2015
An integrated multiplatform bioanalytical strategy for antibody-drug conjugates: a novel case studyHeather Myler, Vangipuram S Rangan, Jian Wang, et al.
Springerplus|September 3, 2016
A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3Graham R Foster, Kazuaki Chayama, Wan-Long Chuang, et al.
Bioanalysis|December 24, 2014
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 3 - LBA and immunogenicity)Lauren Stevenson, Lakshmi Amaravadi, Heather Myler, et al.
Bioanalysis|December 16, 2014
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 1--small molecules by LCMS)Eric Fluhler, Roger Hayes, Fabio Garofolo, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Bioanalysis|February 27, 2016
Validation of an integrated series of ligand-binding assays for the quantitative determination of antibody-drug conjugates in biological matricesHeather Myler, Vangipuram S Rangan, Alex Kozhich, et al.
The AAPS Journal|January 18, 2011
Bioanalytical approaches to quantify "total" and "free" therapeutic antibodies and their targets: technical challenges and PK/PD applications over the course of drug developmentJean W Lee, Marian Kelley, Lindsay E King, et al.
The AAPS Journal|March 15, 2022
Biological Matrix Supply Chain Shortages: More Matrices Are Now Rare-the Case for Surrogate MatricesEvan A Dubiel, Heather Myler, Mark E Arnold, et al.
Bioanalysis|June 21, 2018
Concerted application of LC-MS and ligand binding assays to better understand exposure of a large molecule drugWeifeng Xu, Hao Jiang, Craig Titsch, et al.
Bioanalysis|June 10, 2016
Antibody-drug conjugate bioanalysis using LB-LC-MS/MS hybrid assays: strategies, methodology and correlation to ligand-binding assaysJian Wang, Huidong Gu, Ang Liu, et al.
Diabetes|January 3, 2012
FGF21 analogs of sustained action enabled by orthogonal biosynthesis demonstrate enhanced antidiabetic pharmacology in rodentsJames Mu, Jason Pinkstaff, Zhihua Li, et al.
Bioanalysis|July 31, 2015
An integrated multiplatform bioanalytical strategy for antibody-drug conjugates: a novel case studyHeather Myler, Vangipuram S Rangan, Jian Wang, et al.
Springerplus|September 3, 2016
A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3Graham R Foster, Kazuaki Chayama, Wan-Long Chuang, et al.
Bioanalysis|December 24, 2014
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 3 - LBA and immunogenicity)Lauren Stevenson, Lakshmi Amaravadi, Heather Myler, et al.
Bioanalysis|December 16, 2014
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 1--small molecules by LCMS)Eric Fluhler, Roger Hayes, Fabio Garofolo, et al.
Pageof 4